News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
819,771 Results
Type
Article (76438)
Company Profile (643)
Press Release (742690)
Multimedia
Podcasts (124)
Webinars (14)
Section
Business (227103)
Career Advice (3820)
Deals (39267)
Drug Delivery (129)
Drug Development (89327)
Employer Resources (198)
FDA (17850)
Job Trends (17114)
News (387469)
Policy (38879)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56360)
ALS (104)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (164)
Approvals (17808)
Artificial intelligence (305)
Autoimmune disease (29)
Automation (16)
Bankruptcy (403)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (439)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (312)
Cancer (2480)
Cardiovascular disease (210)
Career advice (3255)
Career pathing (34)
CAR-T (176)
Cell therapy (490)
Cervical cancer (22)
Clinical research (72233)
Collaboration (933)
Company closure (2)
Compensation (578)
Complete response letters (30)
COVID-19 (2868)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2361)
Decentralized trials (2)
Denatured (41)
Depression (56)
Diabetes (302)
Diagnostics (6925)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (93702)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (129005)
Executive appointments (787)
FDA (19277)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (826)
Gene editing (125)
Generative AI (27)
Gene therapy (362)
GLP-1 (861)
Government (5137)
Grass and pollen (6)
Guidances (150)
Healthcare (20876)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (151)
Indications (30)
Infectious disease (3031)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (742)
IPO (17730)
IRA (51)
Job creations (4967)
Job search strategy (2661)
Kidney cancer (11)
Labor market (46)
Layoffs (560)
Leadership (24)
Legal (9970)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (65)
Manufacturing (363)
MASH (81)
Medical device (14623)
Medtech (14628)
Mergers & acquisitions (22103)
Metabolic disorders (806)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2119)
NextGen: Class of 2025 (7639)
Non-profit (5080)
Now hiring (41)
Obesity (433)
Opinion (275)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (22)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (63919)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (22320)
Phase II (31489)
Phase III (23738)
Pipeline (1397)
Policy (179)
Postmarket research (3302)
Preclinical (9871)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (435)
Real estate (7137)
Recruiting (75)
Regulatory (26138)
Reports (58)
Research institute (2655)
Resumes & cover letters (597)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (26)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4190)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (53)
The Weekly (81)
Vaccines (822)
Venture capitalists (45)
Weight loss (306)
Women's health (37)
Worklife (20)
Date
Today (241)
Last 7 days (990)
Last 30 days (3291)
Last 365 days (35151)
2025 (12507)
2024 (37890)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57665)
2019 (51315)
2018 (39095)
2017 (36879)
2016 (37797)
2015 (43773)
2014 (38448)
2013 (34526)
2012 (36478)
2011 (36552)
2010 (36019)
Location
Africa (1205)
Alabama (61)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (48571)
Australia (8369)
California (6672)
Canada (2104)
China (573)
Colorado (289)
Connecticut (305)
Delaware (166)
Europe (110685)
Florida (976)
Georgia (226)
Hawaii (1)
Idaho (63)
Illinois (624)
India (30)
Indiana (342)
Iowa (12)
Japan (177)
Kansas (112)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (991)
Massachusetts (5101)
Michigan (249)
Minnesota (430)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (69)
New Jersey (1875)
New Mexico (31)
New York (1874)
North Carolina (1141)
North Dakota (9)
Northern California (2875)
Ohio (224)
Oklahoma (15)
Oregon (46)
Pennsylvania (1461)
Puerto Rico (14)
Rhode Island (36)
South America (1583)
South Carolina (26)
South Dakota (1)
Southern California (2480)
Tennessee (108)
Texas (994)
United States (25420)
Utah (199)
Virginia (175)
Washington D.C. (72)
Washington State (610)
West Virginia (3)
Wisconsin (70)
819,771 Results for "co don ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025
April 2, 2025
·
5 min read
Employer Resources
Employers’ Markets Don’t Last, Companies Should Focus on Purpose-Driven Culture
While the job market is tough for life sciences professionals right now, it won’t always be. Employers must continue striving to create fulfilling work environments, as the market won’t always be in their favor, say biopharma execs.
March 10, 2025
·
4 min read
·
Chantal Dresner
Earnings
Novavax Sales Jump 600% YoY as COVID-19 Vaccine Still in Limbo at FDA
After more than a month of speculation over how the FDA will rule on Novavax’s application for an updated formulation of its COVID-19 shot, CEO John Jacobs said on the company’s Q1 earnings call: “When we have it, we’ll have it. Until then, we don’t have it.”
May 8, 2025
·
3 min read
·
Heather McKenzie
Press Releases
ALK enters into neffy® co-promotion agreement in the USA
May 5, 2025
·
3 min read
Vaccines
Is the New HHS Vaccine Requirement Anti-Vaccine Activism Disguised as Policy?
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for vaccines and sought greater clarity: “I don’t know what they’re talking about.”
May 7, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
April 2, 2025
·
4 min read
Press Releases
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
April 28, 2025
·
3 min read
C-suite
Pharma’s Biggest Golden Parachutes
Executives don’t just get paid big bucks to operate a company. Sometimes they get paid millions to walk away.
April 23, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Press Releases
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
April 28, 2025
·
8 min read
1 of 81,978
Next
